All Insights
Showing 841 - 852 of 7469
Life Sciences and Healthcare
EU to reform rules for drug-device combinations, product information and pharmacovigilance
The proposal's eight-week consultation has allowed the sector to assess the draft legislation in these and other areas
Financial Services
EU enhances investor protection rules, amending MIFID, UCITS and AIFMD Directives
The EU Commission has proposed a "Retail Investment Strategy" in order to enhance retail investor protection rules. The strategy consists
Energy and Utilities
The Energy Transition | Government removes hydrogen levy on consumer energy bills
Welcome to our top picks of the latest energy regulatory and market developments in the UK's transition to net zero
Retail and Consumer
ICO and CMA clamp down on dark patterns in the UK
Regulators publish joint paper on harmful online design practices
Knowledge Notes
UK Knowledge Collection | SaaS vendor switch, competition in financial services, and high-growth ventures
Welcome to this week's Knowledge Collection
Energy and Utilities
UK strategy for biomass looks to carbon capture and storage to help deliver net zero
Biomass' potential as a renewable energy is endorsed despite controversy around its sustainability credentials
Blockchain
Singapore’s central bank finalises regulatory approach to stablecoins
The regulations target issuers and intermediaries in Singapore and systemic stablecoin arrangement entities
Corporate
Germany's climate tech movement offers impressive returns in drive for sustainability
Start-ups have an important role in helping achieve climate goals – and Germany is keen to support their growth.
Energy and Utilities
The Energy Transition | Industry seeks urgent clarity on the next round of the Demand Flexibility Service
Welcome to our top picks of the latest energy regulatory and market developments in the UK's transition to net zero.
Commercial
SaaS agreements: what to look out for in the UK and EU
SaaS vendor and customer contractual expectations will differ but what are the key provisions and current market practice?
Life Sciences and Healthcare
EU pharmaceutical reforms to overhaul marketing and manufacturing rules
A dvertising, marketing authorisation applications and imports are among the areas targeted by the draft proposals
Life Sciences and Healthcare
Polish reimbursement law changes
A bill to amend the Act on the Reimbursement of Medicines and Certain Other Acts ('the Reimbursement Bill') is pending